Aug 2026
Development of Oligo-PROTACs That Target C/EBPα.
It is demonstrated that these O'PROTACs successfully localize to the nucleus and achieve dose-dependent degradation of C/EBPα, with the most potent candidates exhibiting sub-micromolar DC50 via lipofection delivery.
Junming Cai, Xian-Mei Qi, Adam T. Smiley et al.
· ACS Chemical Biology · 0 citations